89bio, Inc. financial data

Symbol
ETNB on Nasdaq
Location
655 Montgomery Street, Suite 1500, San Francisco, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 8, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.45K % -11.4%
Debt-to-equity 16.8 % +35.5%
Return On Equity -94.5 % -167%
Return On Assets -80.9 % -157%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 148M shares +40%
Common Stock, Shares, Outstanding 148M shares +41.4%
Entity Public Float 722M USD -38.6%
Common Stock, Value, Issued 148K USD +41%
Weighted Average Number of Shares Outstanding, Basic 158M shares +58.1%
Weighted Average Number of Shares Outstanding, Diluted 158M shares +58.1%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 421M USD +168%
General and Administrative Expense 44.6M USD +31.4%
Operating Income (Loss) -466M USD -143%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -449M USD -163%
Income Tax Expense (Benefit) 1.35M USD -67%
Net Income (Loss) Attributable to Parent -450M USD -158%
Earnings Per Share, Basic -3 USD/shares -88.3%
Earnings Per Share, Diluted -3 USD/shares -88.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 129M USD -39.2%
Marketable Securities, Current 432M USD +35.4%
Cash, Cash Equivalents, and Short-term Investments 561M USD +5.61%
Assets, Current 602M USD +3.74%
Property, Plant and Equipment, Net 77K USD +185%
Operating Lease, Right-of-Use Asset 1.26M USD -35.3%
Other Assets, Noncurrent 632K USD +101%
Assets 603M USD +3.67%
Accounts Payable, Current 14.7M USD -16.1%
Employee-related Liabilities, Current 5.02M USD +33.7%
Accrued Liabilities, Current 24.2M USD +29.5%
Liabilities, Current 39.6M USD -4.9%
Operating Lease, Liability, Noncurrent 679K USD -53.6%
Other Liabilities, Noncurrent 5.31M USD +41.5%
Liabilities 81.8M USD +21.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 122K USD
Retained Earnings (Accumulated Deficit) -1.01B USD -80.8%
Stockholders' Equity Attributable to Parent 522M USD +1.32%
Liabilities and Equity 603M USD +3.67%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -71.7M USD -80.6%
Net Cash Provided by (Used in) Financing Activities 269M USD +1179%
Net Cash Provided by (Used in) Investing Activities -7.83M USD +90.2%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 148M shares +41.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 189M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 129M USD -39.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 814K USD +19.9%
Deferred Tax Assets, Valuation Allowance 215M USD +98.3%
Deferred Tax Assets, Gross 215M USD +97.4%
Operating Lease, Liability 1.82M USD -21.4%
Depreciation 10K USD +11.1%
Payments to Acquire Property, Plant, and Equipment 72K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -449M USD -157%
Lessee, Operating Lease, Liability, to be Paid 2.09M USD -27%
Operating Lease, Liability, Current 784K USD +3.29%
Lessee, Operating Lease, Liability, to be Paid, Year Two 937K USD +2.18%
Lessee, Operating Lease, Liability, to be Paid, Year One 917K USD +18.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 277K USD -50.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 240K USD -74.4%
Deferred Tax Assets, Operating Loss Carryforwards 89.3M USD +42%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 5.3M USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 240K USD
Additional Paid in Capital 1.08B USD
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 516K USD -27.8%
Share-based Payment Arrangement, Expense 25M USD +34.5%
Interest Expense 5.96M USD +67.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%